Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yokota

Showing results (401-410 of 11,474) with videos related to

Pageof 1,148
Sort By:
No to Shinkei = Brain and Nerve|January 1, 1979
[Inhibition of nociceptive responses of spinal dorsal horn neurons by periaqueductal gray stimulation (author's transl)]N Nishikawa, T Yokota
International Journal of Hematology|June 19, 2014
Role of tissue-specific AT-rich DNA sequence-binding proteins in lymphocyte differentiationTakafumi Yokota, Yuzuru Kanakura
Infection and Immunity|August 1, 1989
Adherence targets of Vibrio parahaemolyticus in human small intestinesT Yamamoto, T Yokota
Sensors (Basel, Switzerland)|October 29, 2025
Application of Wireless EMG Sensors for Assessing Agonist-Antagonist Muscle Activity During 50-m Sprinting in AthletesKanta Yokota, Hiroyuki Tamaki
Cell and Tissue Research|January 1, 1983
Decentralisation of neurones in the pelvic ganglion of the guinea-pig: reinnervation by adrenergic nervesR Yokota, G Burnstock
Cell and Tissue Research|August 25, 1978
A dividing granule-containing cell in the pelvic ganglion of the guinea-pigR Yokota, G Brunstock
Cells|September 13, 2025
Cardiac Cell and Animal Models for Duchenne Muscular Dystrophy in the Era of Gene Therapy and Precision MedicineHidenori Moriyama, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Creation of DMD Muscle Cell Model Using CRISPR-Cas9 Genome Editing to Test the Efficacy of Antisense-Mediated Exon SkippingRika Maruyama, Toshifumi Yokota
Case Reports in Oncology|June 11, 2020
Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid CarcinomaMasaki Takinami, Tomoya Yokota
Expert Opinion on Drug Safety|December 25, 2024
Is Duchenne gene therapy a suitable treatment despite its immunogenic class effect?Annie Tang, Toshifumi Yokota
Pageof 1,148

Showing results (401-410 of 11,474) with videos related to

Sort By:
Pageof 1,148
No to Shinkei = Brain and Nerve|January 1, 1979
[Inhibition of nociceptive responses of spinal dorsal horn neurons by periaqueductal gray stimulation (author's transl)]N Nishikawa, T Yokota
International Journal of Hematology|June 19, 2014
Role of tissue-specific AT-rich DNA sequence-binding proteins in lymphocyte differentiationTakafumi Yokota, Yuzuru Kanakura
Infection and Immunity|August 1, 1989
Adherence targets of Vibrio parahaemolyticus in human small intestinesT Yamamoto, T Yokota
Sensors (Basel, Switzerland)|October 29, 2025
Application of Wireless EMG Sensors for Assessing Agonist-Antagonist Muscle Activity During 50-m Sprinting in AthletesKanta Yokota, Hiroyuki Tamaki
Cell and Tissue Research|January 1, 1983
Decentralisation of neurones in the pelvic ganglion of the guinea-pig: reinnervation by adrenergic nervesR Yokota, G Burnstock
Cell and Tissue Research|August 25, 1978
A dividing granule-containing cell in the pelvic ganglion of the guinea-pigR Yokota, G Brunstock
Cells|September 13, 2025
Cardiac Cell and Animal Models for Duchenne Muscular Dystrophy in the Era of Gene Therapy and Precision MedicineHidenori Moriyama, Toshifumi Yokota
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Creation of DMD Muscle Cell Model Using CRISPR-Cas9 Genome Editing to Test the Efficacy of Antisense-Mediated Exon SkippingRika Maruyama, Toshifumi Yokota
Case Reports in Oncology|June 11, 2020
Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid CarcinomaMasaki Takinami, Tomoya Yokota
Expert Opinion on Drug Safety|December 25, 2024
Is Duchenne gene therapy a suitable treatment despite its immunogenic class effect?Annie Tang, Toshifumi Yokota
Pageof 1,148